CPHI announces 2022 Excellence in Pharma Award winners

Nov. 3, 2022

Each year since the Pharma Awards inception in 2004, CPHI has recognized outstanding achievements from the global pharma industry across 10 specialist categories.

This year, notable winners include Moderna, who received a special recognition for its development of its Spikevax mRNA-based vaccine. Since its development, Spikevax has received emergency authorization in 70 countries, and more than 807 million doses of the vaccine were shipped globally in 2021.

Another highly competitive category, CEO of the Year, was awarded to Aragen's Manni Kantipudi, for "delivering outstanding performance with sustained growth and robust strategies." 

Just-Evotec Biologics was awarded with the Manufacturing Technology and Equipment recognition for its innovative JPOD. JPOD is a small-footprint, highly automated cGMP manufacturing facility that leverages single-use systems and reconfigurable cleanroom pods for maximum flexibility. The facility can operate clinical or commercial processes in semi- or fully continuous mode with 500-1000L bioreactors.

The full list of this year's winners includes:

CEO of the Year – Manni Kantipudi, Aragen Life Sciences

API Development – Tokuyama Corporation

Finished Formulation – Accord Healthcare

Manufacturing Technology and Equipment – Just-Evotec Biologics

Pharmaceutical Packaging & Drug Delivery - Evonik

Supply Chain, Logistics, and Distribution – HCL Technologies 

Regulatory Procedures and Compliance- Lonza Capsules and Health Ingredients

Digital Innovation – ATMPS

Sustainability – Indaver

Innovation in Response to COVID-19 – Moderna